Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesBetty M. Tijms, Pieter Jelle Visser, Eleonora M. Vromen et al.|Nature Aging|2024Cited by 195
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkersIris E. Jansen, Pablo García‐González, Carolina Dalmasso et al.|Acta Neuropathologica|2022Cited by 138